SDC1 and mucopolysaccharidosis-plus syndrome: Triclabendazole effectively suppressed the exogenously introduced GAG core proteins, including SDC1, BGN, and DCN, both in the MPSPS patient skin fibroblasts and the model cells (Figures 3A and 3B).